Provided by Tiger Trade Technology Pte. Ltd.

Treace Medical Concepts, Inc.

4.65
+0.05001.09%
Post-market: 4.650.00000.00%19:30 EDT
Volume:237.10K
Turnover:1.11M
Market Cap:302.41M
PE:-5.02
High:4.79
Open:4.65
Low:4.55
Close:4.60
52wk High:7.63
52wk Low:1.17
Shares:65.03M
Float Shares:46.95M
Volume Ratio:0.71
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9262
EPS(LYR):-0.9326
ROE:-71.99%
ROA:-17.33%
PB:4.46
PE(LYR):-4.99

Loading ...

Truist Securities Adjusts Price Target on Treace Medical Concepts to $4 From $2, Maintains Hold Rating

MT Newswires Live
·
Jul 16

Ossdsign Names Adam Mccollister Vice President of Sales

Reuters
·
Jun 25

Treace Medical announces first surgical case with HyperPlate XM implant

TIPRANKS
·
Jun 18

Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System

GlobeNewswire
·
Jun 18

Treace Medical CEO John T. Treace acquires TMCI shares worth $210,370

Reuters
·
Jun 12

Treace Medical Concepts to Present at Sidoti Small Cap Conference

Reuters
·
Jun 12

Treace to Present at the Sidoti Small Cap Conference

GlobeNewswire
·
Jun 12

CEO Makes Bold Insider Move at Treace Medical Concepts

TIPRANKS
·
Jun 02

Treace Medical CEO John T. Treace buys TMCI shares worth $177,915

Reuters
·
Jun 02

Major Insider Buy Signals Growing Confidence at Treace Medical Concepts

TIPRANKS
·
May 29

Treace Medical CEO John T. Treace acquires TMCI shares worth USD 339,863.51

Reuters
·
May 29

Treace Medical Shareholders Back Directors, Pay and Auditor

TIPRANKS
·
May 21

Treace Medical CEO John Treace buys USD 400,924 Treace Medical common shares

Reuters
·
May 15

Spotlight On Oramed Pharmaceuticals And Two Other Prominent Penny Stocks

Simply Wall St.
·
May 13

Analysts Conflicted on These Healthcare Names: Treace Medical Concepts (TMCI), NewAmsterdam Pharma Company (NAMS) and LENSAR (LNSR)

TIPRANKS
·
May 11

Treace Medical Concepts, Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Treace Medical Concepts Q1 EPS $(0.28) Beats $(0.31) Estimate, Sales $47.198M Beat $45.960M Estimate

Benzinga Earnings
·
May 08

Treace Medical Q1 net loss widens to $18 million; revenue drops 10% to $47.2 million

Reuters
·
May 08

Treace Medical Concepts, Inc - Reaffirms FY2026 REV Guidance

THOMSON REUTERS
·
May 08

Treace Medical Q1 EPS USD -0.28

THOMSON REUTERS
·
May 08